A study in the Journal of AIDS in March 2012 reported that a common sexually transmitted bacterial infection doubled the risk of HIV infection among women in African. AIDS is published by Lippincott Williams & Wilkins as a part of Wolters Kluwer Health.
Studies have found that women with mycoplasma genitalium infection(STD) are more susceptible to HIV infection. Sue Napierala Mavedzenge, the lead author of the study, said: "If the results of this study are confirmed, then Mycoplasma screening and treatment may be part of the prevention of HIV-1.”
Reproductive mycoplasma infection doubles the risk of HIV infection in women. Data from a study on HIV infection among young women in Zimbabwe and Uganda were used to assess the impact of reproductive Mycoplasma on HIV. It was first discovered in 1980 that Mycoplasma genitalium is a sexually transmitted bacterium that can cause inflammation of the reproductive system (urethritis, cervicitis, pelvic inflammation). Infection can last for years without any symptoms and can be eliminated with appropriate antibiotics.
In this study, 190 HIV-infected women during follow-up were compared with non-HIV-infected women of similar age and risk, Mycoplasma genitalium was tested in both groups. Mycoplasma genitalium was regarded as a risk factor for evaluating HIV infection.
In the original sample, all women were not infected with HIV, about 15% of women who developed HIV infection later had Mycoplasma genitalium infection and only 6.5% of women who did not acquire HIV infection. Mycoplasma genitalium occurs more frequently than other sexually transmitted bacteria such as gonorrhea or chlamydia.
After controlling for other factors, women initially infected with Mycoplasma genitalium infection were twice as likely to be infected with HIV, some other sexually transmitted diseases are also risk factors for HIV infection. The researchers estimated that 90% of all HIV-infected women in the study were attributed to Mycoplasma genitalium.
However, there is also a strong correlation between other factors and the risk of HIV infection, especially the presence of herpes simplex virus type 2 (the virus that causes genital herpes) and the co-existence of other HIV risk factors.
Therefore, in order to prevent HIV infection, timely prevention and active treatment of mycoplasma infection are very necessary, women should go to the regular hospital for diagnosis and treatment in time. Because women infected with mycoplasma can cause other genital inflammation, so in the treatment of female Mycoplasma infection, it is far from enough to rely solely on the efficacy of sterilization and anti-inflammation.
Drugs used to treat mycoplasma infection must also be able to improve the reproductive system environment of patients in an all-round way, and also be able to treat the fertility caused by Mycoplasma at the same time. Fuyan Pill is a conservative natural medicine for treating infertility caused by gynecological diseases and inflammation, it consists of Scutellaria baicalensis, Rhizoma Atractylodis Macrocephalae, Chinese Yam, Angelica sinensis, Licorice, banksia rose, and more than 50 natural herbs. It can not only make Mycoplasma turn negative, but also effectively treat female genital inflammation.
